Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 75,540 | 97,573 | 121,517 | -603,573 | -538,670 |
| Depreciation Amortization | 181,963 | 120,369 | 60,087 | 250,106 | 194,174 |
| Income taxes - deferred | N/A | N/A | N/A | 371,716 | 371,683 |
| Accounts receivable | -49,878 | 76,402 | -57,198 | -133,665 | -47,762 |
| Other Working Capital | -89,624 | -43,044 | -161,513 | -120,217 | -46,319 |
| Other Operating Activity | 155,042 | -23,033 | 86,133 | 237,338 | 119,488 |
| Operating Cash Flow | $273,043 | $228,267 | $49,026 | $1,705 | $52,594 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,141 | -15,919 | -7,367 | -47,181 | -42,664 |
| Net Acquisitions | N/A | N/A | -253,625 | 34,834 | 34,834 |
| Sale Of Investment | N/A | N/A | N/A | 43,017 | N/A |
| Purchase Sale Intangibles | -254,610 | -255,050 | -1,050 | -50,250 | -50,000 |
| Other Investing Activity | -254,610 | -255,050 | -1,050 | -50,250 | -6,983 |
| Investing Cash Flow | $-285,751 | $-270,969 | $-262,042 | $-19,580 | $-14,813 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 300,000 | N/A | N/A |
| Debt Issued | 180,000 | 180,000 | 180,000 | N/A | N/A |
| Debt Repayment | -27,302 | -17,602 | -7,421 | -29,270 | -21,957 |
| Common Stock Issued | 216 | 158 | 5 | 1,400 | 1,385 |
| Other Financing Activity | -9,825 | -4,659 | -4,605 | -17,963 | -17,963 |
| Financing Cash Flow | $143,089 | $157,897 | $467,979 | $-45,833 | $-38,535 |
| Exchange Rate Effect | 447 | 255 | -860 | -2,249 | -967 |
| Beginning Cash Position | 152,822 | 152,822 | 152,822 | 218,779 | 218,779 |
| End Cash Position | 283,650 | 268,272 | 406,925 | 152,822 | 217,058 |
| Net Cash Flow | $130,828 | $115,450 | $254,103 | $-65,957 | $-1,721 |
| Free Cash Flow | |||||
| Operating Cash Flow | 273,043 | 228,267 | 49,026 | 1,705 | 52,594 |
| Capital Expenditure | -31,141 | -15,919 | -7,367 | -47,181 | -42,664 |
| Free Cash Flow | 241,902 | 212,348 | 41,659 | -45,476 | 9,930 |